Theraclion S.A.
ALTHE.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €1 | €0 | €0 | €1 |
| % Growth | 114.8% | -12.1% | -47.5% | – |
| Cost of Goods Sold | €4 | €4 | €4 | €1 |
| Gross Profit | -€3 | -€4 | -€3 | -€0 |
| % Margin | -353.5% | -1,039.3% | -708.4% | -49.3% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | -€1 | €0 | €4 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€0 | €2 | -€0 | -€4 |
| Operating Expenses | -€0 | €1 | -€0 | -€0 |
| Operating Income | -€3 | -€3 | -€3 | €0 |
| % Margin | -338% | -745.3% | -706.6% | 3.1% |
| Other Income/Exp. Net | -€0 | -€0 | €0 | -€2 |
| Pre-Tax Income | -€3 | -€4 | -€3 | -€2 |
| Tax Expense | -€0 | -€0 | -€1 | -€1 |
| Net Income | -€3 | -€3 | -€2 | -€1 |
| % Margin | -304.3% | -873.9% | -534.6% | -142.5% |
| EPS | -0.055 | -0.073 | -0.052 | -0.026 |
| % Growth | 25.1% | -41.6% | -97.3% | – |
| EPS Diluted | -0.055 | -0.073 | -0.052 | -0.026 |
| Weighted Avg Shares Out | 46 | 46 | 46 | 46 |
| Weighted Avg Shares Out Dil | 46 | 46 | 46 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€3 | -€3 | -€3 | -€2 |
| % Margin | -331.4% | -745.3% | -627.5% | -193.6% |